<!DOCTYPE html>
<html lang="en" dir="auto">

<head>
<head>
    <title>rheumatology</title>
    <meta charset="utf-8">
    <meta name="description"
        content="Website meta description for google search results go here" />
    <meta name="dc.relation" content="https://trxiv.yorks0n.com" />
    <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
    <meta name="theme-color" content="#1A94D2" />

    

    
    
    
    <link rel="stylesheet" href="/css/main.min.css" media="screen">

</head>


<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<meta name="robots" content="index, follow">
<title>rheumatology | TRxiv2</title>
<meta name="keywords" content="">
<meta name="description" content="Pathogenic autoantibody internalization in myositis
Authors: Pinal-Fernandez, I.; Munoz-Braceras, S.; Casal-Dominguez, M.; Pak, K.; Torres-Ruiz, J.; Musai, J.; Dell&#39;Orso, S.; Naz, F.; Islam, S.; Gutierrez-Cruz, G.; Dolores Cano, M.; Matas-Garcia, A.; Padrosa, J.; Tobias-Baraja, E.; Garrabou, G.; Aldecoa, I.; Espinosa, G.; Simeon-Aznar, C. P.; Guillen-Del-Castillo, A.; Gil-Vila, A.; Trallero-Araguas, E.; Christopher-Stine, L.; Lloyd, T. E.; Liewluck, T.; Naddaf, E.; Stenzel, W.; Greenberg, S. A.; Maria Grau, J.; Selva-O&#39;Callaghan, A.; Milisenda, J.">
<meta name="author" content="">
<link rel="canonical" href="https://trxiv.yorks0n.com/posts/rheumatology/">
<link crossorigin="anonymous" href="/assets/css/stylesheet.904bd1e751cdd2a584fa6bed3fa1166dfd8ec9949ebfd0c4d69c5add5e17c23d.css" integrity="sha256-kEvR51HN0qWE&#43;mvtP6EWbf2OyZSev9DE1pxa3V4Xwj0=" rel="preload stylesheet" as="style">
<script defer crossorigin="anonymous" src="/assets/js/highlight.f413e19d0714851f6474e7ee9632408e58ac146fbdbe62747134bea2fa3415e0.js" integrity="sha256-9BPhnQcUhR9kdOfuljJAjlisFG&#43;9vmJ0cTS&#43;ovo0FeA="
    onload="hljs.initHighlightingOnLoad();"></script>
<link rel="icon" href="https://trxiv.yorks0n.com/favicon.ico">
<link rel="icon" type="image/png" sizes="16x16" href="https://trxiv.yorks0n.com/favicon-16x16.png">
<link rel="icon" type="image/png" sizes="32x32" href="https://trxiv.yorks0n.com/favicon-32x32.png">
<link rel="apple-touch-icon" href="https://trxiv.yorks0n.com/apple-touch-icon.png">
<link rel="mask-icon" href="https://trxiv.yorks0n.com/safari-pinned-tab.svg">
<meta name="theme-color" content="#2e2e33">
<meta name="msapplication-TileColor" content="#2e2e33">
<noscript>
    <style>
        #theme-toggle,
        .top-link {
            display: none;
        }

    </style>
    <style>
        @media (prefers-color-scheme: dark) {
            :root {
                --theme: rgb(29, 30, 32);
                --entry: rgb(46, 46, 51);
                --primary: rgb(218, 218, 219);
                --secondary: rgb(155, 156, 157);
                --tertiary: rgb(65, 66, 68);
                --content: rgb(196, 196, 197);
                --hljs-bg: rgb(46, 46, 51);
                --code-bg: rgb(55, 56, 62);
                --border: rgb(51, 51, 51);
            }

            .list {
                background: var(--theme);
            }

            .list:not(.dark)::-webkit-scrollbar-track {
                background: 0 0;
            }

            .list:not(.dark)::-webkit-scrollbar-thumb {
                border-color: var(--theme);
            }
        }

    </style>
</noscript><meta property="og:title" content="rheumatology" />
<meta property="og:description" content="Pathogenic autoantibody internalization in myositis
Authors: Pinal-Fernandez, I.; Munoz-Braceras, S.; Casal-Dominguez, M.; Pak, K.; Torres-Ruiz, J.; Musai, J.; Dell&#39;Orso, S.; Naz, F.; Islam, S.; Gutierrez-Cruz, G.; Dolores Cano, M.; Matas-Garcia, A.; Padrosa, J.; Tobias-Baraja, E.; Garrabou, G.; Aldecoa, I.; Espinosa, G.; Simeon-Aznar, C. P.; Guillen-Del-Castillo, A.; Gil-Vila, A.; Trallero-Araguas, E.; Christopher-Stine, L.; Lloyd, T. E.; Liewluck, T.; Naddaf, E.; Stenzel, W.; Greenberg, S. A.; Maria Grau, J.; Selva-O&#39;Callaghan, A.; Milisenda, J." />
<meta property="og:type" content="article" />
<meta property="og:url" content="https://trxiv.yorks0n.com/posts/rheumatology/" /><meta property="article:section" content="posts" />
<meta property="article:published_time" content="2024-01-24T10:40:04+00:00" />
<meta property="article:modified_time" content="2024-01-24T10:40:04+00:00" />

<meta name="twitter:card" content="summary"/>
<meta name="twitter:title" content="rheumatology"/>
<meta name="twitter:description" content="Pathogenic autoantibody internalization in myositis
Authors: Pinal-Fernandez, I.; Munoz-Braceras, S.; Casal-Dominguez, M.; Pak, K.; Torres-Ruiz, J.; Musai, J.; Dell&#39;Orso, S.; Naz, F.; Islam, S.; Gutierrez-Cruz, G.; Dolores Cano, M.; Matas-Garcia, A.; Padrosa, J.; Tobias-Baraja, E.; Garrabou, G.; Aldecoa, I.; Espinosa, G.; Simeon-Aznar, C. P.; Guillen-Del-Castillo, A.; Gil-Vila, A.; Trallero-Araguas, E.; Christopher-Stine, L.; Lloyd, T. E.; Liewluck, T.; Naddaf, E.; Stenzel, W.; Greenberg, S. A.; Maria Grau, J.; Selva-O&#39;Callaghan, A.; Milisenda, J."/>


<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "BreadcrumbList",
  "itemListElement": [, 
    {
      "@type": "ListItem",
      "position":  2 ,
      "name": "Posts",
      "item": "https://trxiv.yorks0n.com/posts/"
    }, 
    {
      "@type": "ListItem",
      "position":  3 ,
      "name": "rheumatology",
      "item": "https://trxiv.yorks0n.com/posts/rheumatology/"
    }
  ]
}
</script>
<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "BlogPosting",
  "headline": "rheumatology",
  "name": "rheumatology",
  "description": "Pathogenic autoantibody internalization in myositis\nAuthors: Pinal-Fernandez, I.; Munoz-Braceras, S.; Casal-Dominguez, M.; Pak, K.; Torres-Ruiz, J.; Musai, J.; Dell\u0026#39;Orso, S.; Naz, F.; Islam, S.; Gutierrez-Cruz, G.; Dolores Cano, M.; Matas-Garcia, A.; Padrosa, J.; Tobias-Baraja, E.; Garrabou, G.; Aldecoa, I.; Espinosa, G.; Simeon-Aznar, C. P.; Guillen-Del-Castillo, A.; Gil-Vila, A.; Trallero-Araguas, E.; Christopher-Stine, L.; Lloyd, T. E.; Liewluck, T.; Naddaf, E.; Stenzel, W.; Greenberg, S. A.; Maria Grau, J.; Selva-O\u0026#39;Callaghan, A.; Milisenda, J.",
  "keywords": [
    
  ],
  "articleBody": " Pathogenic autoantibody internalization in myositis\nAuthors: Pinal-Fernandez, I.; Munoz-Braceras, S.; Casal-Dominguez, M.; Pak, K.; Torres-Ruiz, J.; Musai, J.; Dell'Orso, S.; Naz, F.; Islam, S.; Gutierrez-Cruz, G.; Dolores Cano, M.; Matas-Garcia, A.; Padrosa, J.; Tobias-Baraja, E.; Garrabou, G.; Aldecoa, I.; Espinosa, G.; Simeon-Aznar, C. P.; Guillen-Del-Castillo, A.; Gil-Vila, A.; Trallero-Araguas, E.; Christopher-Stine, L.; Lloyd, T. E.; Liewluck, T.; Naddaf, E.; Stenzel, W.; Greenberg, S. A.; Maria Grau, J.; Selva-O'Callaghan, A.; Milisenda, J. C.; Mammen, A. L.\nScore: 7.6, Published: 2024-01-17 DOI: 10.1101/2024.01.15.24301339\nObjectivesMyositis is a heterogeneous family of autoimmune muscle diseases. As myositis autoantibodies recognize intracellular proteins, their role in disease pathogenesis has been unclear. This study aimed to determine whether myositis autoantibodies reach their autoantigen targets within muscle cells and disrupt the normal function of these proteins. MethodsConfocal immunofluorescence microscopy was used to localize antibodies and other proteins of interest in myositis muscle biopsies. Bulk RNA sequencing was used to study the transcriptomic profiles of 668 samples from patients with myositis, disease controls, and healthy controls. Antibodies from myositis patients were introduced into cultured myoblasts by electroporation and the transcriptomic profiles of the treated myoblasts were studied by bulk RNA sequencing. ResultsIn patients with myositis autoantibodies, antibodies accumulated inside myofibers in the same subcellular compartment as the autoantigen. Each autoantibody was associated with effects consistent with dysfunction of its autoantigen, such as the derepression of genes normally repressed by Mi2/NuRD in patients with anti-Mi2 autoantibodies, the accumulation of RNAs degraded by the nuclear RNA exosome complex in patients with anti-PM/Scl autoantibodies targeting this complex, and the accumulation of lipids within myofibers of anti-HMGCR-positive patients. Internalization of patient immunoglobulin into cultured myoblasts recapitulated the transcriptomic phenotypes observed in human disease, including the derepression of Mi2/NuRD-regulated genes in anti-Mi2-positive dermatomyositis and the increased expression of genes normally degraded by the nuclear RNA exosome complex in anti-PM/Scl-positive myositis. ConclusionsIn myositis, autoantibodies are internalized into muscle fibers, disrupt the biological function of their autoantigen, and mediate the pathophysiology of the disease.\nAnalysis of dietary vitamin C intake levels and the risk of hyperuricemia and gout based on cross-sectional studies and bi-directional Mendelian randomisation\nAuthors: Peng, Z.; Wang, X.; Deng, q.; Yan, w.; Zhao, w.; Pu, y.; liu, n.; Gu, l.; peng, j.\nScore: 3.7, Published: 2024-01-18 DOI: 10.1101/2024.01.18.24301481\nBackgroundVitamin C, a common antioxidant, may be useful for treating hyperuricemia and gout. The aim of this study was to investigate the risk association between dietary vitamin C intake and hyperuricemia/gout and to test for causality using the bi-directional Mendelian randomisation method. MethodsCross-sectional studies were selected from the National Health and Nutrition Examination Survey from 2007-2018 to assess the association between dietary vitamin C intake and the risk of hyperuricemia/gout, according to multivariate logistic regression modelling. Bi-directional Mendelian randomisation studies were conducted using genetic data from large-scale genome-wide association surveys of supplemental vitamin C, pharmacological vitamin C, and ascorbic acid intake and hyperuricemia/gout; these aimed to infer causal relationships between vitamin C and hyperuricemia/gout. Inverse variance weighting was used as the primary method of Mendelian randomisation analysis. A series of sensitivity analyses were used to assess multiplicity. ResultsThe cross-sectional study included 17.52% and 82.48% patients with and without hyperuricemia, respectively, as well as 2.67% and 97.33% patients with and without gout, respectively. In the model correcting for all covariates, the association between vitamin C intake and the risk of hyperuricemia/gout was stable, and the risk of hyperuricemia was generally lower in patients who consumed \u003e111.75 mg vitamin C than in other patients when comparing three models with different moderators. Restricted cubic spline scores indicated that vitamin C intake recommendations of 75-525 mg and 75-225 mg were effective for targeting hyperuricemia and gout, respectively. In inverse variance weighting in the Mendelian randomisation analysis, the amount of vitamin C absorbed was negatively associated with hyperuricemia (OR = 0.985, 95% CI = 0.973-0.997, p = 0.015), and supplemental vitamin C was negatively associated with gout (OR = 0.857, 95% CI = 0.797-0.921, p \u003c 0.001); sensitivity analysis yielded consistent results. Reverse Mendelian randomisation analysis showed that vitamin C had no reverse causal relationship with hyperuricemia and gout. ConclusionWe hypothesise that a dietary vitamin C intake of 75-525 mg or 75-225 mg may reduce the risk of hyperuricemia and gout, respectively. Further research with larger samples is required to confirm this.\n",
  "wordCount" : "711",
  "inLanguage": "en",
  "datePublished": "2024-01-24T10:40:04Z",
  "dateModified": "2024-01-24T10:40:04Z",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://trxiv.yorks0n.com/posts/rheumatology/"
  },
  "publisher": {
    "@type": "Organization",
    "name": "TRxiv2",
    "logo": {
      "@type": "ImageObject",
      "url": "https://trxiv.yorks0n.com/favicon.ico"
    }
  }
}
</script>
</head>

<body class="" id="top">
<script>
    if (localStorage.getItem("pref-theme") === "dark") {
        document.body.classList.add('dark');
    } else if (localStorage.getItem("pref-theme") === "light") {
        document.body.classList.remove('dark')
    } else if (window.matchMedia('(prefers-color-scheme: dark)').matches) {
        document.body.classList.add('dark');
    }

</script>

<header class="header">
    <nav class="nav">
        <div class="logo">
            <a href="https://trxiv.yorks0n.com" accesskey="h" title="TRxiv2 (Alt + H)">TRxiv2</a>
            <div class="logo-switches">
                <button id="theme-toggle" accesskey="t" title="(Alt + T)">
                    <svg id="moon" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24"
                        fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                        stroke-linejoin="round">
                        <path d="M21 12.79A9 9 0 1 1 11.21 3 7 7 0 0 0 21 12.79z"></path>
                    </svg>
                    <svg id="sun" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24"
                        fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                        stroke-linejoin="round">
                        <circle cx="12" cy="12" r="5"></circle>
                        <line x1="12" y1="1" x2="12" y2="3"></line>
                        <line x1="12" y1="21" x2="12" y2="23"></line>
                        <line x1="4.22" y1="4.22" x2="5.64" y2="5.64"></line>
                        <line x1="18.36" y1="18.36" x2="19.78" y2="19.78"></line>
                        <line x1="1" y1="12" x2="3" y2="12"></line>
                        <line x1="21" y1="12" x2="23" y2="12"></line>
                        <line x1="4.22" y1="19.78" x2="5.64" y2="18.36"></line>
                        <line x1="18.36" y1="5.64" x2="19.78" y2="4.22"></line>
                    </svg>
                </button>
            </div>
        </div>
        <ul id="menu">
        </ul>
    </nav>
</header>
<main class="main">
<article class="post-single">
  <header class="post-header">
    
    <h1 class="post-title">
      rheumatology
    </h1>
    <div class="post-meta">&lt;span&gt;updated on January 24, 2024&lt;/span&gt;

</div>
  </header> 
  <div class="post-content"><div class="accordion accordion-flush" id="accordionFlushExample"><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2024.01.15.24301339">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2024.01.15.24301339" aria-expanded="false" aria-controls="flush-collapse10.1101/2024.01.15.24301339">
        <p class="paperTitle">Pathogenic autoantibody internalization in myositis</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2024.01.15.24301339" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2024.01.15.24301339" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Pinal-Fernandez, I.; Munoz-Braceras, S.; Casal-Dominguez, M.; Pak, K.; Torres-Ruiz, J.; Musai, J.; Dell&#39;Orso, S.; Naz, F.; Islam, S.; Gutierrez-Cruz, G.; Dolores Cano, M.; Matas-Garcia, A.; Padrosa, J.; Tobias-Baraja, E.; Garrabou, G.; Aldecoa, I.; Espinosa, G.; Simeon-Aznar, C. P.; Guillen-Del-Castillo, A.; Gil-Vila, A.; Trallero-Araguas, E.; Christopher-Stine, L.; Lloyd, T. E.; Liewluck, T.; Naddaf, E.; Stenzel, W.; Greenberg, S. A.; Maria Grau, J.; Selva-O&#39;Callaghan, A.; Milisenda, J. C.; Mammen, A. L.</p>
        <p class="info">Score: 7.6, Published: 2024-01-17 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2024.01.15.24301339' target='https://doi.org/10.1101/2024.01.15.24301339'> 10.1101/2024.01.15.24301339</a></p>
        <p class="abstract">ObjectivesMyositis is a heterogeneous family of autoimmune muscle diseases. As myositis autoantibodies recognize intracellular proteins, their role in disease pathogenesis has been unclear. This study aimed to determine whether myositis autoantibodies reach their autoantigen targets within muscle cells and disrupt the normal function of these proteins.

MethodsConfocal immunofluorescence microscopy was used to localize antibodies and other proteins of interest in myositis muscle biopsies. Bulk RNA sequencing was used to study the transcriptomic profiles of 668 samples from patients with myositis, disease controls, and healthy controls. Antibodies from myositis patients were introduced into cultured myoblasts by electroporation and the transcriptomic profiles of the treated myoblasts were studied by bulk RNA sequencing.

ResultsIn patients with myositis autoantibodies, antibodies accumulated inside myofibers in the same subcellular compartment as the autoantigen. Each autoantibody was associated with effects consistent with dysfunction of its autoantigen, such as the derepression of genes normally repressed by Mi2/NuRD in patients with anti-Mi2 autoantibodies, the accumulation of RNAs degraded by the nuclear RNA exosome complex in patients with anti-PM/Scl autoantibodies targeting this complex, and the accumulation of lipids within myofibers of anti-HMGCR-positive patients. Internalization of patient immunoglobulin into cultured myoblasts recapitulated the transcriptomic phenotypes observed in human disease, including the derepression of Mi2/NuRD-regulated genes in anti-Mi2-positive dermatomyositis and the increased expression of genes normally degraded by the nuclear RNA exosome complex in anti-PM/Scl-positive myositis.

ConclusionsIn myositis, autoantibodies are internalized into muscle fibers, disrupt the biological function of their autoantigen, and mediate the pathophysiology of the disease.</p>
      </div>
    </div>
  </div><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2024.01.18.24301481">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2024.01.18.24301481" aria-expanded="false" aria-controls="flush-collapse10.1101/2024.01.18.24301481">
        <p class="paperTitle">Analysis of dietary vitamin C intake levels and the risk of hyperuricemia and gout based on cross-sectional studies and bi-directional Mendelian randomisation</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2024.01.18.24301481" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2024.01.18.24301481" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Peng, Z.; Wang, X.; Deng, q.; Yan, w.; Zhao, w.; Pu, y.; liu, n.; Gu, l.; peng, j.</p>
        <p class="info">Score: 3.7, Published: 2024-01-18 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2024.01.18.24301481' target='https://doi.org/10.1101/2024.01.18.24301481'> 10.1101/2024.01.18.24301481</a></p>
        <p class="abstract">BackgroundVitamin C, a common antioxidant, may be useful for treating hyperuricemia and gout. The aim of this study was to investigate the risk association between dietary vitamin C intake and hyperuricemia/gout and to test for causality using the bi-directional Mendelian randomisation method.

MethodsCross-sectional studies were selected from the National Health and Nutrition Examination Survey from 2007-2018 to assess the association between dietary vitamin C intake and the risk of hyperuricemia/gout, according to multivariate logistic regression modelling. Bi-directional Mendelian randomisation studies were conducted using genetic data from large-scale genome-wide association surveys of supplemental vitamin C, pharmacological vitamin C, and ascorbic acid intake and hyperuricemia/gout; these aimed to infer causal relationships between vitamin C and hyperuricemia/gout. Inverse variance weighting was used as the primary method of Mendelian randomisation analysis. A series of sensitivity analyses were used to assess multiplicity.

ResultsThe cross-sectional study included 17.52% and 82.48% patients with and without hyperuricemia, respectively, as well as 2.67% and 97.33% patients with and without gout, respectively. In the model correcting for all covariates, the association between vitamin C intake and the risk of hyperuricemia/gout was stable, and the risk of hyperuricemia was generally lower in patients who consumed &gt;111.75 mg vitamin C than in other patients when comparing three models with different moderators. Restricted cubic spline scores indicated that vitamin C intake recommendations of 75-525 mg and 75-225 mg were effective for targeting hyperuricemia and gout, respectively. In inverse variance weighting in the Mendelian randomisation analysis, the amount of vitamin C absorbed was negatively associated with hyperuricemia (OR = 0.985, 95% CI = 0.973-0.997, p = 0.015), and supplemental vitamin C was negatively associated with gout (OR = 0.857, 95% CI = 0.797-0.921, p &lt; 0.001); sensitivity analysis yielded consistent results. Reverse Mendelian randomisation analysis showed that vitamin C had no reverse causal relationship with hyperuricemia and gout.

ConclusionWe hypothesise that a dietary vitamin C intake of 75-525 mg or 75-225 mg may reduce the risk of hyperuricemia and gout, respectively. Further research with larger samples is required to confirm this.</p>
      </div>
    </div>
  </div>
</div>









<script src="/js/bundle.min.js" defer></script>



  </div>

  <footer class="post-footer">
    <ul class="post-tags">
    </ul>
  </footer>
</article>
    </main>
    
<footer class="footer">
    <span>&copy; 2024 <a href="https://trxiv.yorks0n.com">TRxiv2</a></span>
    <span>
        · Made by Yorkson
    </span>
</footer>
<a href="#top" aria-label="go to top" title="Go to Top (Alt + G)" class="top-link" id="top-link" accesskey="g">
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 12 6" fill="currentColor">
        <path d="M12 6H0l6-6z" />
    </svg>
</a>

<script>
    let menu = document.getElementById('menu')
    if (menu) {
        menu.scrollLeft = localStorage.getItem("menu-scroll-position");
        menu.onscroll = function () {
            localStorage.setItem("menu-scroll-position", menu.scrollLeft);
        }
    }

    document.querySelectorAll('a[href^="#"]').forEach(anchor => {
        anchor.addEventListener("click", function (e) {
            e.preventDefault();
            var id = this.getAttribute("href").substr(1);
            if (!window.matchMedia('(prefers-reduced-motion: reduce)').matches) {
                document.querySelector(`[id='${decodeURIComponent(id)}']`).scrollIntoView({
                    behavior: "smooth"
                });
            } else {
                document.querySelector(`[id='${decodeURIComponent(id)}']`).scrollIntoView();
            }
            if (id === "top") {
                history.replaceState(null, null, " ");
            } else {
                history.pushState(null, null, `#${id}`);
            }
        });
    });

</script>
<script>
    var mybutton = document.getElementById("top-link");
    window.onscroll = function () {
        if (document.body.scrollTop > 800 || document.documentElement.scrollTop > 800) {
            mybutton.style.visibility = "visible";
            mybutton.style.opacity = "1";
        } else {
            mybutton.style.visibility = "hidden";
            mybutton.style.opacity = "0";
        }
    };

</script>
<script>
    document.getElementById("theme-toggle").addEventListener("click", () => {
        if (document.body.className.includes("dark")) {
            document.body.classList.remove('dark');
            localStorage.setItem("pref-theme", 'light');
        } else {
            document.body.classList.add('dark');
            localStorage.setItem("pref-theme", 'dark');
        }
    })

</script>
</body>

</html>
